Results 1 to 10 of about 371,201 (312)

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis [PDF]

Frontiers in Oncology, 2020
Background: To examine the potential prognostic significance of pretreatment De Ritis ratio (aspartate transaminase/alanine transaminase ratio) in urological cancers, including upper tract urothelial cancer (UTUC), renal cell carcinoma (RCC), prostate ...
Shiqiang Su, Lizhe Liu, Chao Li, Jin Zhang, Shen Li   +4 more
doaj   +3 more sources

Prognostic Value of Aspartate Transaminase/Alanine Transaminase Ratio in Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Undergoing Hepatectomy [PDF]

Frontiers in Oncology, 2022
BackgroundAspartate transaminase/alanine transaminase (De Ritis) ratio is a good predictor of liver function damage, but its prognostic value in patients with hepatocellular carcinoma (HCC) undergoing hepatectomy remains unclear.
Qiuyan Mo, Yingchun Liu, Yingchun Liu, Zihan Zhou, Zihan Zhou, Runwei Li, Wenfeng Gong, Bangde Xiang, Weizhong Tang, Weizhong Tang, Hongping Yu, Hongping Yu, Hongping Yu, Hongping Yu   +13 more
doaj   +3 more sources

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center. [PDF]

Onco Targets Ther, 2019
Purpose: The aim of this study was to evaluate the prognostic value of the aspartate transaminase/alanine transaminase (AST/ALT) ratio in a large Chinese cohort surgically treated for localized upper tract urothelial carcinoma (UTUC) using propensity ...
Li Y, Fang D, Bao Z, He A, Guan B, He S, Zhan Y, Gong Y, Li X, Zhou L.   +9 more
europepmc   +4 more sources

The association of aspartate transaminase-to-alanine transaminase ratio and metabolic syndrome among HIV patients in Sidama Region, South Ethiopia [PDF]

SAGE Open Medicine, 2023
Objective: Studies on the association of the aspartate transaminase-to-alanine transaminase ratio with the metabolic syndrome and its components among HIV patients were scarce.
Wondwossen Abera, Temesgen Bizuayehu Wube, Tsegaye Alemayehu   +2 more
doaj   +2 more sources

FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis. [PDF]

World J Gastroenterol
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) with hepatic histological NAFLD activity score ≥ 4 and fibrosis stage F ≥ 2 is regarded as “at risk” non-alcoholic steatohepatitis (NASH).
Yin JY, Yang TY, Yang BQ, Hou CX, Li JN, Li Y, Wang Q.   +6 more
europepmc   +2 more sources

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients. [PDF]

Onco Targets Ther, 2019
Background Numerous studies have reported the association between pretreatment serum aspartate transaminase to alanine transaminase (AST/ALT) ratio and prognosis in multiple cancers.
Wu J, Chen L, Wang Y, Tan W, Huang Z, Huang Z.   +5 more
europepmc   +2 more sources

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study. [PDF]

Dis Markers, 2019
Introduction To investigate the correlation between preoperative De Ritis ratio (aspartate transaminase (AST)/alanine transaminase (ALT)) and postoperative outcome in patients with urothelial cell carcinoma (UC) treated with radical cystectomy. Materials
Yuk HD, Jeong CW, Kwak C, Kim HH, Ku JH.
europepmc   +2 more sources

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. [PDF]

BMJ Open Gastroenterol, 2019
Background and aims Non-invasive assessment of fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) is challenging, especially in resource-limited settings.
Kolhe KM, Amarapurkar A, Parikh P, Chaubal A, Chauhan S, Khairnar H, Walke S, Ingle M, Pandey V, Shukla A.   +9 more
europepmc   +2 more sources

Disproportional exaggerated aspartate transaminase is a useful prognostic parameter in late leptospirosis.

World Journal of Gastroenterology, 2005
AIM To evaluate the hepatic dysfunction in leptospirosis is usually mild and resolved eventually. However, sequential follow-up of liver biochemical data remained lacking..
Ming-Ling Chang, Chih‐Wei Yang, Jeng-Chang Chen, Y. Ho, M. Pan, Cheng-Hui Lin, D. Lin   +6 more
semanticscholar   +3 more sources

Interaction of difluoro-oxaloacetate with aspartate transaminase [PDF]

Biochemical Journal, 1977
Diffluoro-oxaloacetate behaves as a competitive inhibitor of 2-oxoglutarate and as an uncompetitive inhibitor with respect to aspartate in steady-state kinetic experiments with cytoplasmic aspartate transaminase. In the presence of high concentrations of aspartate transaminase, difluoro-oxaloacetate is slowly transaminated to difluoro-aspartate ...
P A, Briley, R, Eisenthal, R, Harrison, G D, Smith   +3 more
openaire   +4 more sources